16 January 2025
16 January 2025
Despite a strong end to the year, the genomics company's 2024 revenues dropped by 2% from 2023.
MedTech Europe’s report reflects a lack of clarity over requirements, rising costs, and decreases in innovation activities.
The research activities are set to be conducted at UCSF facilities in the San Francisco Bay Area, California.
The company’s one-year study demonstrated the superiority of the ReActiv8 system for treating chronic low back pain over the SoC.
Ventura Capital led the funding round and participated with other current investors.
The Centers for Medicare and Medicaid Services (CMS) has approved the implants for New Technology Add-on Payment (NTAP).
The WHO has reported a “high” regional and national risk from the haemorrhagic virus while the global risk remains low.
The clearance marks the receipt of second authorisation for the company from the FDA.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
